Both in Pharmaceuticals
Pyxis Oncology vs Foghorn Therapeutics
Over the past year PYXS returned −50.0% and FHTX returned −53.6%; their daily moves had a correlation of 0.16.
PYXS −50.0% FHTX −53.6%Growth of $1, one year, split-adjusted
| Metric | PYXS | FHTX |
|---|---|---|
| Price | $1.68 | $1.85 |
| Market cap | $140.1M | $109.9M |
| Today | −6.67% | −2.12% |
| 1 month | −50.7% | −56.0% |
| 6 months | +1.2% | −65.0% |
| Year to date | +46.1% | −65.7% |
| 1 year | −54.1% | −58.1% |
| Revenue growth (YoY) | −100.0% | +112.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −44.7% |
| P/E (TTM) | — | — |
| Price / sales | 12.7× | 3.0× |
| Net cash | $33.0M | $167.6M |
| Dividend yield | — | — |
| Volatility (60d) | 121.7% | 106.8% |
| Short % of float | 8.8% | 6.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).